2020 International Congress of Diabetes and Metabolism

S1 Diabetic complications 1 : Transforming landscape of diabetic kidney disease On-Air Channel A	09:10~11:10 / Friday 18 September Chairman:In Joo Kim, Kang Seo Park	Overview
This session entitled ‘Transforming landscape of diabetic kidney disease’ is prepared to provide recent evidence for clinicians and researchers having interest in diabetic kidney disease. Experts in this field will cover various but balanced aspects of kidney diseases in the context of newer anti-diabetes drugs including SGLT2 inhibitors. State of the art multiomics approach will also be covered.
David Z. Cherney University of Toronto, Canada	1-1SGLT2 Inhibitors and kidney protection beyond diabetes
Soon Hyo Kwon Soonchunghyang University, Korea	1-2Diabetic medications and albuminuria
Sang Soo Kim Pusan National University, Korea	1-3Anti-diabetes drugs and GFR
Nan Hee Kim Korea University, Korea	1-4Multiomics approach in DKD research

S7 Diabetic complications 2 : Diabetic brain and extremities On-Air Channel A	16:20~18:20 / Friday 18 September Chairman:Hyun Shik Son, Yeon-Ah Sung	Overview
Diabetes markedly increases the risk of cerebral and peripheral atherosclerosis. In addition to that, until a cure for diabetes is found, hypoglycemia will continue to be a major barrier to the achievement of long-term glucose control and will cause recurrent morbidity in individuals with diabetes. This session ‘Diabetic Brain and Extremities’ could help prepare to implement appropriate medical and interventional treatments to reduce the disability and death of diabetic patients.
Meng Lee Chang Gung University, Taiwan	7-1Blood glucose, antidiabetic drugs, and stroke risk
Ji-Young Kim Inje University, Korea	7-2Hypoglycemia and brain
Pil Hyung Lee University of Ulsan, Korea	7-3Screening and diagnosis of diabetic peripheral arterial disease
Su Hong Kim Busan Veterans Hospital, Korea	7-4Updated current treatment of DM PAD

S12 Epidemiology & genetics : Precision medicine based on Korean registry/cohort On-Air Channel B	09:00~11:00 / Saturday 19 September Chairman:Jeong Taek Woo, Chang Beom Lee	Overview
Current epidemiology research for diabetes has not only presented simple statistics, but has been developed to be used as an evidence for personalized diabetes care in connection with basic, translational research in various fields such as artificial intelligence and multi-omics. In this session, we will introduce the results of cutting-edge research on personalized diabetes treatment conducted based on major diabetes epidemiology data for Koreans.
Choong Hwan Lee Konkuk University, Korea	12-1Prediction of diabetes complications based on metabolomics: KNDP omics study
Hyuk-Jae Chang Yonsei University, Korea	12-2Deep learning prediction for CVD and DM
Young Jin Kim Korea National Institute of Health, Korea	12-3Genomics-based prediction of diabetes and diabetes complications
Dae Jung Kim Ajou University, Korea	12-4 The effectiveness of new diabetes drugs, SGLT2 inhibitors: real world evidence

Main symposia